Articles from Antidepressants

Primary tabs

Ketamine-like drug for depression gets UK licence - The Guardian

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 18:02

Ketamine-like drug for depression gets UK licence The Guardian

Read more about Ketamine-like drug for depression gets UK licence - The Guardian
Log in to post comments

Abnormal CRP May Be a Biomarker of Major Depression in Schizophrenia - Psychiatry Advisor

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 18:00

Abnormal CRP May Be a Biomarker of Major Depression in Schizophrenia Psychiatry Advisor

FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines - Bloomberg Law

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 17:34

FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines Bloomberg Law

Read more about FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines - Bloomberg Law
Log in to post comments

FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines - Bloomberg Law

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 17:34

FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines Bloomberg Law

Read more about FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines - Bloomberg Law
Log in to post comments

SPRAVATO (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Small Molecules | News Channels - PipelineReview.com

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 16:49

SPRAVATO (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Small Molecules | News Channels PipelineReview.com

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder - Business Wire

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 10:19

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder Business Wire

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder - Odessa American

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 10:19

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder Odessa American

Antidepressant Drugs Market Outlook 2020-2029 | Demand | Future Roadmap | Geographical Regions Analysis - Neptune Pine

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 09:57

Antidepressant Drugs Market Outlook 2020-2029 | Demand | Future Roadmap | Geographical Regions Analysis Neptune Pine

I Think About These a Lot - Bon Appetit

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 09:22

I Think About These a Lot Bon Appetit

Read more about I Think About These a Lot - Bon Appetit
Log in to post comments

SUNDAYS AFTER: Patrick Shepard finds healing in basketball - Minneapolis Star Tribune

Submitted by Anonymous (not verified) on Thu, 12/19/2019 - 08:21

SUNDAYS AFTER: Patrick Shepard finds healing in basketball Minneapolis Star Tribune

Read more about SUNDAYS AFTER: Patrick Shepard finds healing in basketball - Minneapolis Star Tribune
Log in to post comments

Main menu

Articles from Antidepressants

Primary tabs

Ketamine-like drug for depression gets UK licence - The Guardian

Abnormal CRP May Be a Biomarker of Major Depression in Schizophrenia - Psychiatry Advisor

FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines - Bloomberg Law

FDA Warns of Breathing Issues With Seizure, Nerve Pain Medicines - Bloomberg Law

SPRAVATO (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder | Small Molecules | News Channels - PipelineReview.com

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder - Business Wire

SPRAVATO® (Esketamine) Nasal Spray Approved in Europe for Adults with Treatment-Resistant Major Depressive Disorder - Odessa American

Antidepressant Drugs Market Outlook 2020-2029 | Demand | Future Roadmap | Geographical Regions Analysis - Neptune Pine

I Think About These a Lot - Bon Appetit

SUNDAYS AFTER: Patrick Shepard finds healing in basketball - Minneapolis Star Tribune

Pages

Main menu

You are here

User login

Articles from Antidepressants

Primary tabs

Pages